Gastroenterology and Hepatology

Episodes 46-52 of 52

• 

  RestartResume

  The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care – Chair’s Perspective

  CME/CE

  The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care – Chair’s Perspective

  • 

    

    Naim Alkhouri, MD, FAASLD, DABOM

    Peer

  0.25 credits

• 

  RestartResume

  Building Bridges, Closing Gaps in NASH Care: The Pivotal Role of Gastroenterologists

  CME/CE

  Building Bridges, Closing Gaps in NASH Care: The Pivotal Role of Gastroenterologists

  • 

    

    Kimberly A. Brown, MD

    Peer

• 

  RestartResume

  The NASH Epidemic: Highlights from the AMCP 2023 Symposium

  CME/CE

  The NASH Epidemic: Highlights from the AMCP 2023 Symposium

  • 

    

    Mazen Noureddin, MD, MHSc

    Peer

• 

  RestartResume

  In Your Waiting Room: The Virtual IBS-C Patient Clinical Experience

  CME/CE

  In Your Waiting Room: The Virtual IBS-C Patient Clinical Experience

  • 

    

    Darren Brenner, MD

    Peer

  • 

    

    Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE

    Peer

• 

  RestartResume

  Virtual IBD Clinic: Updates in Diagnostic, Therapeutic, and Prognostic Strategies

  CME/CE

  Virtual IBD Clinic: Updates in Diagnostic, Therapeutic, and Prognostic Strategies

  • 

    

    Sushila R. Dalal, MD

    Peer

• 

  RestartResume

  Virtual IBD Clinic: Surgical and Pharmacological Therapeutics

  CME/CE

  Virtual IBD Clinic: Surgical and Pharmacological Therapeutics

  • 

    

    Jenny S. Sauk, MD

    Peer
• advertisement

• 

  RestartResume

  Unresectable HCC: An Emerging Era of Combination Therapy – A Clinical Convergence^®

  CME/CE

  Unresectable HCC: An Emerging Era of Combination Therapy – A Clinical Convergence^®

  • 

    

    Richard S. Finn, MD

    Peer

  • 

    

    Amit Singal, MD, MS

    Peer

  • 

    

    Mark Yarchoan, MD

    Peer

• Prev
• 1
• 2
• 3
• 4